Domino reaction of arylaldehydes and 1-acetylcyclopropanecarboxamides: One-pot access to highly functionalized spiropiperidine-2,4-diones

Tetrahedron Letters

Volumn 51, Issue 48, 2010, Pages 6349-6352

  Liu, Jing ^a   Lin, Shaoxia ^a   Ding, Hongqian ^a   Wei, Ying ^a   Liang, Fushun ^a  

^a NORTHEAST NORMAL UNIVERSITY   (China)

Author keywords

Ketoamides; Arylaldehydes; Domino reaction; Michael addition; Piperidine 2,4 diones

Indexed keywords

1 ACETYLCYCLOPROPANECARBOXAMIDE; ALDEHYDE DERIVATIVE; AMIDE; PIPERIDINE DERIVATIVE; SPIROPIPERIDINE 2,4 DIONE; UNCLASSIFIED DRUG;

ALDOL REACTION; ARTICLE; CHEMICAL REACTION; CHEMICAL STRUCTURE; DOMINO REACTION; MICHAEL ADDITION; MOLECULAR MECHANICS; ONE POT SYNTHESIS; STEREOCHEMISTRY;

EID: 78049409621     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2010.09.133     Document Type: Article

References (51)

1. S.L. Schreiber Science 287 2000 1964
2. B.M. Trost Science 254 1991 1471
3. B.M. Trost Angew. Chem., Int. Ed. Engl. 34 1995 258
4. B.M. Trost Acc. Chem. Res. 35 2002 695
5. K.C. Nicolaou, D.J. Edmonds, and P.G. Bulger Angew. Chem., Int. Ed. 45 2006 7134
6. For reviews, see: D. Enders, C. Grondal, and M.R.M. Hüttl Angew. Chem., Int. Ed. 46 2007 1570
7. D.W.C. MacMillan, and A.M. Walji Synlett 2007 1477
8. For reviews on domino reactions: L.F. Tiete Chem. Rev. 96 1996 115
9. S.E. Denmark, and A. Thorarensen Chem. Rev. 96 1996 137
10. M. Malacria Chem. Rev. 96 1996 289
11. P.J. Parsons, C.S. Penkett, and A.J. Shell Chem. Rev. 96 1996 195
12. K. Neuschütz, J. Velker, and R. Neier Synthesis 1998 227
13. G. Poli, G. Giambastiani, and A. Heumann Tetrahedron 56 2000 5959
14. A.J. McCarroll, and J.C. Walton Angew. Chem., Int. Ed. 40 2001 2224
15. L.F. Tietze, and U. Beifuss Angew. Chem., Int. Ed. Engl. 32 1993 131
16. A. Bunce Tetrahedron 51 1995 13103
17. K.C. Nicolaou, T. Montagnon, and S.A. Snyder Chem. Commun. 2003 551
18. A. de Meijere, P. von Zezschwitz, and S. Bräse Acc. Chem. Res. 38 2005 413
19. X. Cheng, F. Liang, F. Shi, L. Zhang, and Q. Liu Org. Lett. 11 2009 93
20. F. Liang, X. Cheng, J. Liu, and Q. Liu Chem. Commun. 2009 3636
21. F. Liang, J. Zhang, J. Tan, and Q. Liu Adv. Synth. Catal. 348 2006 1986
22. F. Liang, D. Li, L. Zhang, J. Gao, and Q. Liu Org. Lett. 9 2007 4845
23. Y. Li, F. Liang, X. Bi, and Q. Liu J. Org. Chem. 71 2006 8006
24. Y. Li, X. Xu, J. Tan, P. Liao, J. Zhang, and Q. Liu Org. Lett. 12 2010 244
25. For selected representative reactions from β-ketoamides, see: B. Jiang, S.-J. Tu, P. Kaur, W. Wever, and G. Li J. Am. Chem. Soc. 131 2009 11660
26. F. Liéby-Muller, T. Constantieux, and J. Rodriguez J. Am. Chem. Soc. 127 2005 17176
27. C.-Y. Zhou, and C.-M. Che J. Am. Chem. Soc. 129 2007 5828
28. B. Lu, and D. Ma Org. Lett. 8 2006 6115
29. D. Xiang, K. Wang, Y. Liang, G. Zhou, and D. Dong Org. Lett. 10 2008 345
30. J.M. Ramanjulu, M.P. DeMartino, Y. Lan, and R. Marquis Org. Lett. 12 2010 2270
31. For pharmacuetical application of piperidine-2,4-diones, see: (a) 3,3-diethyl-5-methyl-piperidine-2,4-dione (methyprylon) is used for insomnia and daytime tension, which is categorized under the following by the FDA: Sedatives and Hypnotics; ATC code: N05CE02; (b) N-arylpiperidine-2,4-dione derivatives may be used as abnormal cannabidiols agents for lowering intraocular pressure, Eur. Pat. Appl. EP 2 123 264 A1.
32. For examples of piperidine-2,4-diones as intermediates in organic synthesis, see: K. Asahia, and H. Nishinob Tetrahedron 61 2005 11107
33. K. Asahia, and H. Nishinob Tetrahedron Lett. 47 2006 7259
34. For recent examples towards piperidine-4-dione and piperidine-2,4-dione synthesis, see: L. Cui, and L. Zhang J. Am. Chem. Soc. 131 2009 8394
35. A. Palillero, J.L. Teran, D. Gnecco, J.R. Juarez, M.L. Orea, and A. Castro Tetrahedron Lett. 50 2009 4208
36. F.A. Davis, B. Chao, Y.W. Andemichael, P.K. Mohanty, T. Fang, D.M. Burns, A. Rao, and J.M. Szewczyk Heteroat. Chem. 13 2002 486
37. Spiro compounds represent an important class of naturally occurring substances characterized by highly pronounced biological properties. For a review on the stereo-controlled synthesis of spiro compounds, see: M. Sannigrahi Tetrahedron 55 1999 9007
38. Spirocyclopropanes are present in a number of pharmacologically interesting natural products, such as the cytotoxic illudins. For selected papers see: M.C. Pirrung, and H. Liu Org. Lett. 5 2003 1983
39. N. Rasool, M.A. Rashid, M. Adeel, H. Görls, and P. Langer Tetrahedron Lett. 49 2008 2254
40. N. Rasool, M.A. Rashid, H. Reinke, C. Fischer, and P. Langer Tetrahedron 64 2008 3246
41. G. Bose, and P. Langer Tetrahedron Lett. 45 2004 3861
42. CCDC 771686 (3a) contains the supplementary crystallographic data for this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data-request/cif.
43. 4: C, 78.33; H, 5.88; N, 4.81; found: C, 78.30; H, 5.89; N, 4.79.
44. For synthetic details, see Supplementary data.
45. The yields corresponding to products 3 could not be further improved after several trials.
46. It was observed in our experimental that even though excessive arylaldehyde was introduced to the reaction system, there is a strong tendency for the formation of compounds 3.
47. An example for further transformation, see: P.B. Alper, C. Meyers, A. Lerchner, D.R. Siegel, and E.M. Carreira Angew. Chem., Int. Ed. 38 1999 3186
48. For a recent review on organo-catalytic asymmetric aza-Michael addition, see: D. Enders, C. Wang, and J.X. Liebich Chem. Eur. J. 15 2009 11058
49. For selected papers, see: M. Lu, D. Zhu, Y. Lu, Y. Hou, B. Tan, and G. Zhong Angew. Chem., Int. Ed. 47 2008 10187
50. D. Zhu, M. Lu, P. Chua, B. Tan, F. Wang, X. Yang, and G. Zhong Org. Lett. 10 2008 4585
51. For a minireview on conjugate additions-triggered tandem transformation, see: H.-C. Guo, and J.-A. Ma Angew. Chem., Int. Ed. 45 2006 354